mitochondrial replacement therapy

Researchers identify unique cases in which people inherited mitochondrial DNA not just from their mother but also from their father.

The team that oversaw the first use of mitochondrial replacement therapy that resulted in a live birth has published an account of the procedure.

Meet some of the people featured in the January 2017 issue of The Scientist.

This year, the developers of CRISPR gene-editing technology argued over patent rights, a researcher fought to unmask anonymous PubPeer commenters, US regulators considered “three-parent” babies, and troubles continued for Theranos.

Mitochondrial replacement therapy raises important societal and ethical concerns, but should be embraced for its utility in preventing disease.

Parliament voted to allow mitochondrial replacement therapy last year. This latest decision suggests we may see babies born from the technique in the country in 2017.

Differences in the replicative advantages conferred by some mitochondrial DNA haplotypes have implications for mitochondrial replacement therapy, researchers report. 

Theranos’s bad blood tests; presidential science lessons; “three-parent” babies

Scientists in Mexico achieved the infant’s conception using mitochondrial replacement therapy.